![](https://news.europawire.eu/wp-content/uploads/2023/10/servier-logo_n-144x144.jpg)
(IN BRIEF) Servier, a global pharmaceutical group, has partnered with Owkin, a biotech company specializing in AI-driven drug discovery and diagnostics, to accelerate the development of better-targeted therapies in various disease areas, including oncology. The collaboration aims to leverage AI … Read the full press release